In a groundbreaking advancement poised to redefine the landscape of gene delivery and therapeutic interventions, a team of researchers at Tokyo Metropolitan University has engineered a novel polymer-based vehicle designed to transport DNA into cells more efficiently and with minimal side effects. This innovative molecule circumvents the traditional challenges encountered with positively charged delivery systems, offering a more biocompatible solution with the potential to revolutionize gene therapy and vaccination strategies.
Traditional methods of introducing DNA or RNA into cells often rely heavily on delivery agents bearing a strong positive charge. This characteristic exploits the negatively charged nature of genetic material, enabling the formation of complexes that facilitate cellular uptake. However, this electrostatic approach is fraught with significant disadvantages. Chief among them is the propensity of positively charged polymers to elicit inflammatory responses at the injection site, a problem that complicates clinical applications. Additionally, such charged carriers tend to nonspecifically interact with other negatively charged biological molecules and components of the extracellular matrix, leading to aggregation and reduced delivery efficiency.
Recognizing these limitations, Professor Shoichiro Asayama and his team synthesized an uncharged polymer conjugated with a thymine base—the nitrogenous component traditionally known for its role in DNA structure. The polymer backbone selected for this molecule is poly(ethylene glycol) (PEG), a polymer acclaimed for its inertness and biocompatibility in biological systems. Crucially, the conjugation is not just a random attachment; the thymine base is strategically employed to interact specifically with DNA strands, enhancing the stability and specificity of the DNA-polymer complex.
The binding mechanism leverages annealing—a process well known in molecular biology where a double-stranded DNA (dsDNA) molecule partially unwinds when subjected to mild heating. This local unwinding exposes the thymine bases on the DNA, allowing for hydrogen bonding interactions with the thymine moieties on the PEG polymer. These weak, non-covalent hydrogen bonds result in the formation of what the researchers have termed a “single nucleobase-terminal complex” (SNTC). This complex maintains neutrality in charge, thereby significantly reducing the risk of inflammation and nonspecific aggregates traditionally seen with cationic carriers.
The research group meticulously optimized the ratio of thymine-PEG molecules to DNA strands, determining conditions under which DNA uptake into cells is maximized. In vivo experiments conducted with murine models revealed a striking enhancement in gene expression levels—up to fourteen times greater than those achieved with unmodified DNA. This marked improvement evidences the superior uptake facilitated by SNTC, showcasing its promise as a next-generation DNA delivery vehicle that combines efficiency with safety.
The implications of this technology extend far beyond the laboratory. Gene therapy has long been heralded as a transformative approach to treating genetic disorders, cancers, and infectious diseases. However, the delivery bottleneck has consistently hampered progress, with delivery systems either lacking effectiveness or introducing adverse immune reactions. By providing a neutral, biocompatible complex with enhanced cellular entry capabilities, the new polymer-based approach could catalyze the development of safer and more effective gene-based therapeutics.
Moreover, vaccine development stands to benefit imminently. DNA vaccines, which rely on delivering plasmid DNA encoding antigenic proteins, have faced obstacles due to inefficient gene uptake and inflammatory side effects. Employing the thymine-PEG polymer as a carrier could elevate gene expression in target cells, amplifying the immune response while simultaneously mitigating adverse reactions, a balance that is critical in vaccine acceptance and success.
This innovation also highlights the importance of supramolecular chemistry in biomedical engineering. The strategic use of hydrogen bonding—an exquisitely tunable and reversible interaction—facilitates the specific assembly of delivery complexes at physiological temperatures. This approach marks a departure from traditional reliance on electrostatic interactions and opens avenues for designing delivery vehicles with tailored specificity and minimal toxicity.
From a materials science perspective, the choice of PEG as the polymer backbone underscores a thoughtful integration of known biocompatible materials with innovative molecular design. PEG’s longstanding record in medical applications provides confidence in the translational potential of this approach, likely easing regulatory pathways compared to entirely novel synthetic polymers.
Looking ahead, the versatility of the SNTC could enable its adaptation to diverse nucleic acid payloads, including RNA molecules, enabling broad-spectrum applications in gene regulation, vaccination, and beyond. Additional research will be oriented toward elucidating the precise cellular uptake mechanisms and optimizing the delivery system for different tissues and disease targets.
This promising research was supported by significant grants from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), underscoring the strategic national interest in fostering innovations in gene delivery technologies.
By transcending the constraints imposed by charged delivery systems, this thymine-modified PEG polymer ushers in a new era of gene therapy vehicles that marry efficacy with safety. Its capacity to dramatically enhance gene expression in vivo not only accelerates the pace of biomedical innovation but also holds the promise of tangible benefits for patients worldwide facing genetic and infectious diseases.
Subjected to peer review, the research detailing the synthesis, characterization, and in vivo application of this molecule was published in ACS Applied Bio Materials, an esteemed journal showcasing cutting-edge interdisciplinary research at the interface of chemistry, biology, and materials science.
As the scientific community continues to pursue the holy grail of efficient, safe, and targeted gene delivery, the approach pioneered by Professor Asayama’s team represents a beacon of hope, revealing a sophisticated yet straightforward solution grounded in fundamental chemistry and innovative engineering principles.
The pioneering combination of annealing-induced complex formation with nucleobase specificity charts a course toward smart biomaterials that communicate seamlessly with biological systems—an instrumental step in realizing the full therapeutic potential of nucleic acid-based medicine.
Subject of Research: Development of a neutral polymer-DNA complex for enhanced in vivo gene delivery using thymine-modified poly(ethylene glycol)
Article Title: Annealing of pDNA to Form the Single-Nucleobase-Terminal Complex for In Vivo Gene Expression
News Publication Date: 16-Jan-2026
Web References:
DOI: 10.1021/acsabm.5c02207
Image Credits: Tokyo Metropolitan University
Keywords
Drug delivery; Plasmids; Annealing; Biomaterials; Biomedical engineering; Hydrogen bonding; Intramuscular injections; Supramolecular chemistry; Thymine; Gene therapy; Gene expression
